Tizanidine Tablet
Product Images NDC 80425-0187

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 80425-0187). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Pharmacy Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Fig 1 (Fig 1)

Fig 1 (Fig 1)
FDA Label Image

Fig 2 (Fig 2)

Fig 2 (Fig 2)
FDA Label Image

Fig 3 (Fig 3)

Fig 3 (Fig 3)
The text describes a study evaluating the improvement in Ashworth Score using a mean dose of 26.8 mg over the course of 7 weeks. The Ashworth Score is likely a measure of muscle spasticity in a certain population. The study includes a titration period and a maintenance period. The last observation carried forward is the endpoint of the study.*
FDA Label Image

Structure (Structure)

Structure (Structure)
FDA Label Image

Tizanidine #30 (Tizanidine HCl 2mg Tab Qty 30 Ndc 80425 0187)

Tizanidine #30 (Tizanidine HCl 2mg Tab Qty 30 Ndc 80425 0187)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.